echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The fifth batch of national procurement is about to implement the prices of these drugs will rise instead of falling

    The fifth batch of national procurement is about to implement the prices of these drugs will rise instead of falling

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    1

    1

    An average decrease of 56%

    An average decrease of 56%

    The results of the highly anticipated fifth batch of national procurements were officially announced, but the discussions brought to the industry went far beyond that


    "Overcoming card points, sudden change in centralized procurement pattern" and "shopping injection market" made the centralized procurement quite dramatic


    355 products from 201 companies participated in the bidding, and 251 products from 148 pharmaceutical companies were eligible for selection


    After the results of the centralized procurement plan were announced, in addition to the self-deprecating "can announce the unemployment list of medical representatives", employees of a pharmaceutical company revealed to Cyberlan that the price of potassium chloride release tablets after the centralized procurement was higher than before the centralized procurement, and the cephalosporin injections General price increases


    2

    2

    The price of buying with quantity is no longer jumping off property?

    The price of buying with quantity is no longer jumping off property?

    Cybelan’s inquiry found that potassium chloride sustained-release tablets (0.


    Shanghai Sunshine Purchasing Network announces the selected companies

    However, on a drug purchase website that ordinary users can buy, potassium chloride sustained-release tablets (0.


    According to relevant media reports, the selected prices of some drugs such as ceftazidime for injection, ceftriaxone, and acyclovir tablets are lower than the purchase prices of clinics and other institutions


    In the five centralized procurements, the overall price reduction of more than 50% of the participating companies has basically become the "standard equipment for admission", and the decline is comparable


    An industry insider explained to Cyberlan that consistency evaluation is the threshold for generic drugs to participate in centralized procurement


    According to the statistics of Medicine Rubik's Cube in 2020, there are 108 medicines (including the new 4 categories deemed to have passed) that have passed the consistency evaluation announced by listed companies, of which 87 are less than 10 million yuan, and 21 are equal to or higher than 10 million yuan.


    On March 25, 2020, the official website of the State Food and Drug Administration announced that the import, sale and use of paclitaxel for injection (albumin-bound) of Celgene Corporation (Celgene Corporation) was suspended


    In order to avoid the emergence of "winning bids" for selected products, the National Medical Insurance Administration pays more attention to the supply of selected products


    The National Medical Insurance Bureau uses the entire chain of production, circulation, and use of monitoring and supervision to ensure the quality supply and priority use of selected products, which increases the performance costs of related companies


    "With the advancement of centralized procurement, companies have more experience in centralized procurement, and the quotations are more rational, which is more conducive to the sustainable development of the enterprise in the future


    Respecting the reasonable profits of pharmaceutical companies has become an industry consensus


    3

    3

    "Super Group Buying" Forces Pharmaceutical Companies to Transform

    "Super Group Buying" Forces Pharmaceutical Companies to Transform

    In the past collective purchases, most of them went out of the circle with "price cuts"


    In order to further verify the safety and effectiveness of the generic drugs selected in centralized procurement, the National Medical Insurance Bureau has also cooperated with the Beijing Municipal Health Commission to organize 20 top-tier tertiary hospitals in Beijing to carry out real-world research
    .
    This two-year study collected data from 110,000 patients during real use
    .
    Among them, 35,450 patients used entecavir, which scientifically confirmed that the efficacy of the generic drug entecavir in the treatment of hepatitis B patients was consistent with the original drug
    .
    Some generic drugs even perform better than the original drugs in terms of adverse reactions
    .

    The term "quality" is frequently mentioned by the National Medical Insurance Administration
    .
    On January 29, Chen Jinfu, deputy director of the National Medical Security Administration, said at the State Council’s regular policy briefing that the quality of biosimilars must be a priority consideration for the inclusion of biosimilars in centralized procurement, and the rules must be more in line with market requirements
    .

    According to Chen Jinfu, the new procurement system has effectively eliminated the accumulative disadvantages of sales with gold, squeezed out the gray cost space in the drug circulation process, and guided companies to transform marketing models.
    Some companies have significantly increased their R&D investment, which is conducive to the formation of a clear market.
    Qizheng's drug circulation and use links are also conducive to promoting the high-quality development of the pharmaceutical industry
    .

    For pharmaceutical companies, centralized procurement can be exchanged for volume, sales and sales channels are guaranteed, the cost of intermediate circulation links is reduced, and reasonable profit margins are guaranteed.
    It is also possible to reshape the competitive landscape and seize a larger share.
    Market share
    .
    From the point of view of the purchase amount, the leading companies have gained a lot
    .
    The "big bargaining company" Qilu Pharmaceutical became the biggest winner of this centralized procurement, with a total purchase amount of 390 million yuan
    .
    Kelun Pharmaceutical, which was ridiculed as "taking a shopping cart to participate in collective procurement", selected 11 products and 18 specifications, ranking fifth with an amount of 340 million yuan
    .

    Under the normalization of centralized procurement, the living space of generic drugs has been compressed, forcing enterprises to transform to R&D and innovation
    .
    Centralized procurement will accelerate the substitution of domestic products, reduce the dependence on imported drugs; improve the operating efficiency of selected companies, and promote the increase in the concentration of the generic drug industry
    .
    Ping An Securities previously analyzed that large domestic generic drug companies rely on low cost and multiple varieties to survive, but the valuation may not be high
    .

    "Centralized sourcing will bring about a change next, that is, in addition to the original research drugs, foreign companies will increase the speed of introducing innovative drugs into the Chinese market in the future, and adjust their product structure
    .
    Massive centralized sourcing will make more companies realize that high-profit The acquisition still lies in innovative drugs, and pharmaceutical companies are encouraged to make efforts on innovative drugs
    .
    " Gu Hai, director of the Center for Health Policy and Management Research of Nanjing University, introduced to Cyberland
    .

    As a "weapon" of the National Medical Insurance Administration, mass procurement is reshaping the pattern of the pharmaceutical industry and is also questioning pharmaceutical companies.
    Should they continue to fight in the fiery centralized procurement of generic drugs, or take advantage of the favorable policies for innovative drugs to enter the game? Different people have different opinions on how to weigh the layout and create greater profits
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.